US Penicillin G Sodium Market Faces Continued Downward Pressure in July

US Penicillin G Sodium prices continued to remain softer in July 2026 as leading generic manufacturers halted bulk spot procurement and relied entirely on safety stocks accumulated during Q2. Ample inventory levels across the supply chain, coupled with subdued seasonal demand, reduced the need for fresh purchases and kept the Penicillin G Sodium market under pressure. The current market weakness follows developments seen in June, when increased export availability from China and front-loaded imports into the United States boosted distributor inventories. According to ChemAnalyst data, Penicillin G Sodium CFR Houston prices averaged USD 31,254/MT in June, down from USD 32,665/MT in May. Demand from hospitals, GPOs, and sterile injectable manufacturers remained muted, while outpatient penicillin prescription activity declined during the summer season. Import supply of Penicillin G Sodium remains readily available as Chinese producers continue operating at stable fermentation rates and aggressively placing material into the US market to maintain utilization levels. Elevated inventory positions and consistent import arrivals are expected to limit buying urgency. As a result, Penicillin G Sodium prices are anticipated to remain soft in the near term, although feedstock cost pressures and seasonal logistics risks could influence market sentiment later in the year.